PLURIPOTENT stem cells are derived from a blastocyst which is the stage of an embryo 0-4 days after fusion of an egg and a spermatozoa.
A decade ago, in order to produce such a blastocyst and derive PLURIPOTENT stem cells from it, our scientists needed to retrieve eggs from a woman and collect sperm from a male and then fertilize the egg in a petri dish. Nowadays, it is no longer necessary to retrieve eggs or sperm to produce a blastocyst. Our scientists are able to produce an egg from a skin cell. They are also able to fuse such an egg with a fibroblast (skin cell) to produce an embryo.
In other words, our PLURIPOTENT stem cells are produced by transforming skin cells into PLURIPOTENT stem cells following several advanced scientific steps. The blastocyst produced in the process of this transformation is a transient stage where the skin cell is fully returned to its original PLURIPOTENT stage. No life is being produced or destroyed. There is only a transformation of old living cells into young and more effective ones.
HMC is a unique company in the world offering PLURIPOTENT stem cells. PLURIPOTENT stem-cells are up to 6x more potent in their ability to help the human body heal itself than that of adult-stem-cells or umbilical-stem-cells. While AUTOLOGUS PLURIPOTENT stem-cells are up to 10x more potent.
HMC stem cells are always delivered fresh from the laboratory culture. We never provide frozen stem cells to our partnered doctors as it would reduce the efficacy and number of stem-cells available for use by your body after injection.
We work with doctors to ensure that stem-cells are counted prior to injection, without any additional freezing. This ensures that patients always receive a minimum of 20 million stem-cells per injection. Some clinics or doctors purchase stem-cells in a frozen state, and simply ‘defrost’ them prior to injection, so even if there were 20 million stem-cells prior to freezing, by the time they reach your body, you are receiving less stem-cells than you were told, or possibly none at all!
Regardless of who you choose for your stem-cell therapy, make sure that the stem cell count is done in the last stage – prior to injection and without additional freezing.
To date, Stem Cell therapy has produced no negative side effects; nor are there any medically or scientifically anticipated risks outside that of a routine outpatient injection.
There is no scientific evidence that PLURIPOTENT stem cells may cause cancer. In fact, PLURIPOTENT stem-cells are the only stem-cells that have been scientifically proven to produce anti-tumor proteins that can shrink and even kill tumors. Others, including umbilical stem-cells and adult stem-cells, do not have this anti-cancer affect. In the many years in which our cells have been utilized, we have never seen such a problem after ESC treatment, on the contrary, we have seen tumors shrink and disappear.
Our PLURIPOTENT stem cells (ESC) are continually cultured in our labs. They were originally derived from a 100-200 cell blastocyst (either donated or cloned from a skin-cell) which is an early stage embryo, only 5 days old. At this very early stage, these cells have not yet become specialized in any way. In other words, they have not begun to transform (differentiate) into skin cells, bone cells, muscle cells etc.
Once a particular stem cell line has been established, it can be cultured for many years without losing potency or effectiveness and, most importantly, without the need of additional blastocysts.